In research by Bian et al., it is stated that Ribosomal protein L13a (RPL13A) is a good reference gene to use when adjusting the expression levels of genes in ovarian cancer cells after they have been treated with anti-cancer drugs such as paclitaxel and 10-hydroxy camptothecin [74]. This evidence concerns the gene RPL13A and ovarian cancer.